Bac-to-Bac™ Vector Kit
Bac-to-Bac™ Vector Kit
Gibco™

Bac-to-Bac™ Vector Kit

Bac-to-Bac™ Vector Kitには、pFastBac™ 1ベクターと、Bac-to-Bac™ Baculovirus Expression System(カタログ番号10359-016詳細を見る
製品番号(カタログ番号)数量
103600141 kit
製品番号(カタログ番号) 10360014
価格(JPY)
111,100
Each
お問い合わせください ›
数量:
1 kit
Bac-to-Bac™ Vector Kitには、pFastBac™ 1ベクターと、Bac-to-Bac™ Baculovirus Expression System(カタログ番号10359-016)の一部として使用する発現コントロールベクターが含まれており、昆虫細胞で発現試験を行うための組換えバキュロウイルスの効率的な生成を可能にします。Bac-to-Bac™ Systemは昆虫細胞の相同組換えではなく、大腸菌における部位に特異的な転位による組換えバキュロウイルスの生成に依存します(図1)。このシステムの特長は以下のとおりです。

時間を節約する発現バクミド。Bac-to-Bac™では、pFastBac™ベクターの発現カセットがDH10Bac™大腸菌コンピテントセル(このベクターキットには含まれません)の親バクミドで組換えを行い、発現バクミドを形成します。その後、組換えバキュロウイルス粒子の生成のために、バクミドを昆虫細胞にトランスフェクションします。
簡単なコロニースクリーニング。DH10Bac™大腸菌の親バクミドは、lacZα遺伝子のセグメントを含みます。lacZα遺伝子が発現カセットの転位時に破壊されることによって、バクミドに組み込むことで、組換えの青白選択が可能になります。これにより、組換えコロニーの同定が容易になります。
Bac-to-Bac™ Baculovirus Expression Systemは、組換えバキュロウイルスの迅速で小規模な生成のために設計されています。このキットではpFastBac™ 1ベクターが付属しており、タンパク質発現のための強力なポリヘドリンプロモーターと、クローニングを簡素化する大規模な複数のクローニング部位を提供します。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
製品タイプベクターキット
数量1 kit
ベクターpFastBac
クローニング法制限酵素/MCS
製品ラインBac-to-Bac
プロモーターポリヘドリン
タンパク質タグタグなし
Unit SizeEach
組成および保存条件
10 µgのpFastBac™1ベクターおよびpFastBac™ 1-Gusコントロールベクターを含みます。

-20℃で保管してください。

よくあるご質問(FAQ)

I cannot grow this white colony in liquid culture. What should I do?

The concentration of gentamicin might be too high. Try lowering the amount to 5 µg/mL and try adding more of the colony to the culture medium.

What has happened when I see blue colonies? How about colonies which are blue in the center and white on the edges?

In the case of a blue colony, the E. coli has the bacmid and the plasmid in it, allowing the cells to survive the selection process. However, because the transposition has not occurred, the LacZ gene is not disrupted. For bulls-eye colonies, this indicates that the transposition took place when the colony was growing. Re-streaking for an isolated clone from the white portion of the mixed colony should yield some colonies where transposition occurred.

I'm getting mostly white/wild-type plaques instead of blue/recombinant plaques. What am I doing wrong?

This is typically an indication of poor homologous recombination. Check the plasmid/linear DNA ratio you used. If there are some blue plaques, however, expand those viruses and check for their protein. In our experience, they are correct, even if they were in relatively low abundance.

I've infected my cells and see large polyhedra in one cell and smaller polyhedra (more numerous) in a neighboring cell. Is this normal?

Yes, cells are infected with wild-type virus individually and will develop polyhedra at different rates until all the cells in the flask are infected. The polyhedra in cells will form in approximately 3-4 days, differing in size and number until they reach their maximum capacity and burst the cell, releasing tiny particles of virus into the medium.

I'm worried that I am not getting plaques. How many days does it take to see plaques and what size are they typically?

Normally, very small white dots show up about 5-7 days and 1 mm plaques show up around day 10. Plaques can vary in size from 1 mm to 4 mm.

引用および参考文献 (12)

引用および参考文献
Abstract
Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin.
Authors: Dan C; Kelly A; Bernard O; Minden A;
Journal:J Biol Chem
PubMed ID:11413130
'PAK4 is the most recently identified member of the PAK family of serine/threonine kinases. PAK4 differs from other members of the PAK family in sequence and in many of its functions. Previously, we have shown that an important function of this kinase is to mediate the induction of filopodia in ... More
Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120.
Authors: Dai G; Steede N K; Landry S J;
Journal:J Biol Chem
PubMed ID:11551929
'The specificity and intensity of CD4(+) helper T-cell responses determine the effectiveness of immune effector functions. Promiscuously immunodominant helper T-cell epitopes in the human immunodeficiency virus (HIV) envelope glycoprotein gp120 could be important in the development of broadly protective immunity, but the underlying mechanisms of immunodominance and promiscuity remain poorly ... More
Interaction of Fibroblast Growth Factor Receptor 3 and the Adapter Protein SH2-B. A ROLE IN STAT5 ACTIVATION.
Authors: Kong Monica; Wang Ching S; Donoghue Daniel J;
Journal:J Biol Chem
PubMed ID:11827956
'Fibroblast growth factor receptor 3 (FGFR3) influences a diverse array of biological processes, including cell growth, differentiation, and migration. Activating mutations in FGFR3 are associated with multiple myeloma, cervical carcinoma, and bladder cancer. To identify proteins that interact with FGFR3 and which may mediate FGFR3-dependent signaling, a yeast two-hybrid screen ... More
Functional differences between the human ATP-dependent nucleosome remodeling proteins BRG1 and SNF2H.
Authors: Aalfs J D; Narlikar G J; Kingston R E;
Journal:J Biol Chem
PubMed ID:11435432
'ATP-dependent nucleosome remodeling complexes can be grouped into several classes that may differ in their biochemical remodeling activities and biological roles. Although there are a number of biochemical studies of each class of remodeler, there are very little data directly comparing the biochemical activities of remodelers from different classes. We ... More
PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
Authors:Nishida T, Yasuda H,
Journal:J Biol Chem
PubMed ID:12177000
The androgen receptor (AR) has been shown to be modified by SUMO-1, a ubiquitin-like protein. Recently we showed that PIAS family proteins function as SUMO-E3 ligases. Here we provide evidence that PIAS1 and PIASxalpha act as specific SUMO-E3 ligases for the AR. PIAS1 and PIASxalpha but not PIAS3 or PIASxbeta ... More